GI-Cell partners with Helixmith and Cartexell to develop cell therapy technology

BIO-EUROPE SPRING 2022_GICELL corporate presentation

GI Innovation·GI Cell·Yonsei University Health System, Signed MoU to establish a cell therapy center for advanced biopharmaceutical

GI Cell sets new record in culturing highly active natural killer cells

GICELL, selected as a company to present ‘Biotech Showcase 2022’

GICELL acquired a manufacturing license for advanced biopharmaceuticals and is selected as an eligible entity for the Smart Factory Construction and Advancement Project.